PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1916570
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1916570
Biotech Ingredients Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of biotech ingredients Market
The global biotech ingredients market size was valued at USD 2.32 billion in 2025 and is projected to grow to USD 2.50 billion in 2026, further reaching USD 4.54 billion by 2034. The market is expanding due to increasing adoption of biotechnology-based production methods across pharmaceuticals, cosmetics, food and beverages, and agriculture. In 2025, North America dominated the market with a 45% share, supported by advanced biomanufacturing infrastructure and high R&D investments.
Biotech ingredients are produced using processes such as fermentation, enzymatic synthesis, cell culture, genetic engineering, and synthetic biology. These ingredients include enzymes, amino acids, peptides, vitamins, probiotics, and active pharmaceutical ingredients (APIs). Compared to chemically synthesized ingredients, biotech ingredients offer higher purity, sustainability, scalability, and consistency, which strengthens their adoption in regulated industries.
Market Drivers Supporting Growth
One of the major drivers is the growing demand for sustainable and clean-label ingredients across consumer and industrial sectors. In food and beverages, biotechnology-derived enzymes and probiotics help improve digestion, enhance shelf life, and meet clean-label requirements. In cosmetics, microbial-derived hyaluronic acid, peptides, and ceramides are increasingly preferred due to safety and eco-friendly sourcing.
In pharmaceuticals, biotech ingredients are critical for producing biologics, vaccines, monoclonal antibodies, and recombinant proteins. Rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders is increasing reliance on biologic therapies, directly raising demand for biotech-derived APIs and excipients.
Market Restraints Limiting Expansion
Despite strong growth prospects, high R&D and production costs remain major restraints. Developing biotech ingredients requires sophisticated laboratory facilities, skilled scientists, long development cycles, and regulatory compliance, particularly in pharmaceutical-grade production. Fermentation and cell-culture systems require precise environmental control, increasing operational costs.
Regulatory approvals further extend timelines, especially in biologics manufacturing where safety, traceability, and validation are critical. Smaller companies often face difficulty scaling production due to limited capital availability, which restricts market entry and competitiveness.
Market Opportunities from Advanced Therapies and Biosimilars
Patent expirations of blockbuster biologics have accelerated the development of biosimilars, creating strong demand for fermentation-based proteins, growth media, and purification reagents. This trend is particularly strong in oncology and autoimmune disease treatment.
Advanced therapies such as cell therapies, gene therapies, CAR-T therapies, and antibody-drug conjugates are also expanding globally. These therapies require specialized biotech ingredients, including viral vectors, recombinant cytokines, and engineered proteins, creating new long-term demand streams across regulated healthcare markets.
Market Challenges from Regulatory and Geopolitical Factors
Regulatory complexity remains a significant challenge. Approval frameworks differ across the U.S., Europe, and Asia, requiring separate documentation, testing protocols, and environmental assessments. Synthetic biology and genetically modified microbial strains often face additional scrutiny, slowing commercialization.
Geopolitical tensions and trade protectionism are also affecting ingredient supply chains. Tariffs, export controls, and dependency on Chinese and Indian raw material sourcing are forcing manufacturers to diversify production locations, increasing capital expenditure and compliance burden.
Segmentation Analysis by Source and Application
By Source
The market is segmented into animal-based, plant-based, and microbial ingredients.
Animal-based ingredients dominated in 2024, driven by high bioavailability of collagen, gelatin, and hormone-based compounds used in pharmaceuticals and nutraceuticals.
Plant-based ingredients are growing due to vegan demand and sustainability trends, supported by enzyme-assisted extraction technologies.
The microbial segment is projected to contribute about 46% globally in 2026, driven by precision fermentation, CRISPR strain optimization, and high-yield microbial synthesis.
By Application
The market is segmented into pharmaceuticals, food and beverages, personal care and cosmetics, and others.
The pharmaceuticals segment held about 45.60% share in 2026, driven by biologics, vaccines, and recombinant APIs.
Food and beverages are expanding due to rising demand for probiotics, enzymes, and functional proteins.
Personal care and cosmetics are growing due to biotech peptides, hyaluronic acid, and vegan collagen used in skin repair and anti-aging products.
The food and beverages segment accounted for approximately 15.8% share in 2024.
Regional Outlook
North America
North America recorded USD 1.06 billion in 2025 and USD 1.14 billion in 2026, remaining the largest regional market. The U.S. alone is projected to reach USD 0.90 billion by 2026, supported by biologics manufacturing and clean-label cosmetic demand.
Asia Pacific
Asia Pacific is experiencing rapid growth due to strong government funding and expanding biomanufacturing.
China is projected to reach USD 0.21 billion by 2026, India USD 0.11 billion, and Japan USD 0.05 billion, driven by pharmaceutical production and fermentation investments.
Europe
Europe benefits from sustainability regulations and strong biotech research. Germany is projected to reach USD 0.26 billion by 2026, while the UK is expected to reach USD 0.11 billion.
Latin America and Middle East & Africa
Growth is supported by expanding pharmaceutical manufacturing and rising adoption of bio-based cosmetic ingredients, especially in Brazil and Gulf countries.
Competitive Landscape and Industry Developments
Major companies include Givaudan, Codex-ing Biotech Ingredients, Covalo, dsm-firmenich, Abel, Evonik Industries, Merck KGaA, Conagen, Fermenta Biotech, and Titan Biotech. These companies focus on expanding fermentation capacity, launching sustainable ingredients, and forming strategic partnerships.
Key developments include private equity investments, new fermentation-based flavor launches, AI-driven ingredient formulation tools, vegan collagen introductions, and large-scale biomanufacturing expansions in the U.S. and Asia during 2024-2025.
Conclusion
The biotech ingredients market is showing strong structural growth, with market value increasing from USD 2.32 billion in 2025 to USD 2.50 billion in 2026 and projected to reach USD 4.54 billion by 2034, supported by rising adoption across pharmaceuticals, food and beverages, and personal care applications. North America remains the leading region, while Asia Pacific is emerging as a high-growth manufacturing and R&D hub. Expansion of biologics, biosimilars, and advanced therapies is accelerating demand for fermentation-based proteins, enzymes, and recombinant APIs, while clean-label and sustainability trends are boosting plant-based and microbial ingredient development. Although high production costs and regulatory complexity continue to challenge market participants, ongoing investments in precision fermentation, synthetic biology, and AI-driven bioprocess optimization are improving scalability and efficiency, strengthening long-term industry competitiveness and widening commercial adoption across both healthcare and consumer sectors.
Segmentation By Source
- Microbial
- Plant-based
- Animal-based
By Application
- Pharmaceuticals
- Food and Beverages
- Personal Care & Cosmetics
- Others
By Region
- North America (By Source, By Application, and By Country)
- U.S. (By Application)
- Canada (By Application)
- Europe (By Source, By Application, and By Country)
- Germany (By Application)
- France (By Application)
- U.K. (By Application)
- Italy (By Application)
- Rest of Europe (By Application)
- Asia Pacific (By Source, By Application, and By Country)
- China (By Application)
- India (By Application)
- Japan (By Application)
- South Korea (By Application)
- Rest of Asia Pacific (By Application)
- Latin America (By Source, By Application, and By Country)
- Brazil (By Application)
- Mexico (By Application)
- Rest of Latin America (By Application)
- Middle East & Africa (By Source, By Application, and By Country)
- Saudi Arabia (By Application)
- South Africa (By Application)
- Rest of Middle East & Africa (By Application)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Trends
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Market Opportunities
- 3.5. Market Challenges
4. Key Insights
- 4.1. Key Market Trends in the Global Market
- 4.2. Key Developments: Mergers, Acquisitions, Partnerships, etc.
- 4.3. Latest Technological Advancement
- 4.4. Insights on Sustainability
- 4.5. Porter's Five Forces Analysis
- 4.6. Tariff Impact Analysis
5. Global Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Key Findings / Summary
- 5.2. By Source
- 5.2.1. Microbial
- 5.2.2. Plant-based
- 5.2.3. Animal-based
- 5.3. By Application
- 5.3.1. Pharmaceuticals
- 5.3.2. Food and Beverages
- 5.3.3. Personal Care & Cosmetics
- 5.3.4. Others
- 5.4. By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Key Findings / Summary
- 6.2. By Source
- 6.2.1. Microbial
- 6.2.2. Plant-based
- 6.2.3. Animal-based
- 6.3. By Application
- 6.3.1. Pharmaceuticals
- 6.3.2. Food and Beverages
- 6.3.3. Personal Care & Cosmetics
- 6.3.4. Others
- 6.4. By Country
- 6.4.1. U.S.
- 6.4.1.1. By Application
- 6.4.1.1.1. Pharmaceuticals
- 6.4.1.1.2. Food and Beverages
- 6.4.1.1.3. Personal Care & Cosmetics
- 6.4.1.1.4. Others
- 6.4.1.1. By Application
- 6.4.2. Canada
- 6.4.2.1. By Application
- 6.4.2.1.1. Pharmaceuticals
- 6.4.2.1.2. Food and Beverages
- 6.4.2.1.3. Personal Care & Cosmetics
- 6.4.2.1.4. Others
- 6.4.2.1. By Application
- 6.4.1. U.S.
7. Europe Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Key Findings / Summary
- 7.2. By Source
- 7.2.1. Microbial
- 7.2.2. Plant-based
- 7.2.3. Animal-based
- 7.3. By Application
- 7.3.1. Pharmaceuticals
- 7.3.2. Food and Beverages
- 7.3.3. Personal Care & Cosmetics
- 7.3.4. Others
- 7.4. By Country
- 7.4.1. Germany
- 7.4.1.1. By Application
- 7.4.1.1.1. Pharmaceuticals
- 7.4.1.1.2. Food and Beverages
- 7.4.1.1.3. Personal Care & Cosmetics
- 7.4.1.1.4. Others
- 7.4.1.1. By Application
- 7.4.2. UK
- 7.4.2.1. By Application
- 7.4.2.1.1. Pharmaceuticals
- 7.4.2.1.2. Food and Beverages
- 7.4.2.1.3. Personal Care & Cosmetics
- 7.4.2.1.4. Others
- 7.4.2.1. By Application
- 7.4.3. France
- 7.4.3.1. By Application
- 7.4.3.1.1. Pharmaceuticals
- 7.4.3.1.2. Food and Beverages
- 7.4.3.1.3. Personal Care & Cosmetics
- 7.4.3.1.4. Others
- 7.4.3.1. By Application
- 7.4.4. Italy
- 7.4.4.1. By Application
- 7.4.4.1.1. Pharmaceuticals
- 7.4.4.1.2. Food and Beverages
- 7.4.4.1.3. Personal Care & Cosmetics
- 7.4.4.1.4. Others
- 7.4.4.1. By Application
- 7.4.5. Rest of Europe
- 7.4.5.1. By Application
- 7.4.5.1.1. Pharmaceuticals
- 7.4.5.1.2. Food and Beverages
- 7.4.5.1.3. Personal Care & Cosmetics
- 7.4.5.1.4. Others
- 7.4.5.1. By Application
- 7.4.1. Germany
8. Asia-Pacific Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Key Findings / Summary
- 8.2. By Source
- 8.2.1. Microbial
- 8.2.2. Plant-based
- 8.2.3. Animal-based
- 8.3. By Application
- 8.3.1. Pharmaceuticals
- 8.3.2. Food and Beverages
- 8.3.3. Personal Care & Cosmetics
- 8.3.4. Others
- 8.4. By Country
- 8.4.1. China
- 8.4.1.1. By Application
- 8.4.1.1.1. Pharmaceuticals
- 8.4.1.1.2. Food and Beverages
- 8.4.1.1.3. Personal Care & Cosmetics
- 8.4.1.1.4. Others
- 8.4.1.1. By Application
- 8.4.2. India
- 8.4.2.1. By Application
- 8.4.2.1.1. Pharmaceuticals
- 8.4.2.1.2. Food and Beverages
- 8.4.2.1.3. Personal Care & Cosmetics
- 8.4.2.1.4. Others
- 8.4.2.1. By Application
- 8.4.3. Japan
- 8.4.3.1. By Application
- 8.4.3.1.1. Pharmaceuticals
- 8.4.3.1.2. Food and Beverages
- 8.4.3.1.3. Personal Care & Cosmetics
- 8.4.3.1.4. Others
- 8.4.3.1. By Application
- 8.4.4. South Korea
- 8.4.4.1. By Application
- 8.4.4.1.1. Pharmaceuticals
- 8.4.4.1.2. Food and Beverages
- 8.4.4.1.3. Personal Care & Cosmetics
- 8.4.4.1.4. Others
- 8.4.4.1. By Application
- 8.4.5. Rest of Asia-Pacific
- 8.4.5.1. By Application
- 8.4.5.1.1. Pharmaceuticals
- 8.4.5.1.2. Food and Beverages
- 8.4.5.1.3. Personal Care & Cosmetics
- 8.4.5.1.4. Others
- 8.4.5.1. By Application
- 8.4.1. China
9. Latin America Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Key Findings / Summary
- 9.2. By Source
- 9.2.1. Microbial
- 9.2.2. Plant-based
- 9.2.3. Animal-based
- 9.3. By Application
- 9.3.1. Pharmaceuticals
- 9.3.2. Food and Beverages
- 9.3.3. Personal Care & Cosmetics
- 9.3.4. Others
- 9.4. By Country
- 9.4.1. Brazil
- 9.4.1.1. By Application
- 9.4.1.1.1. Pharmaceuticals
- 9.4.1.1.2. Food and Beverages
- 9.4.1.1.3. Personal Care & Cosmetics
- 9.4.1.1.4. Others
- 9.4.1.1. By Application
- 9.4.2. Mexico
- 9.4.2.1. By Application
- 9.4.2.1.1. Pharmaceuticals
- 9.4.2.1.2. Food and Beverages
- 9.4.2.1.3. Personal Care & Cosmetics
- 9.4.2.1.4. Others
- 9.4.2.1. By Application
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Application
- 9.4.3.1.1. Pharmaceuticals
- 9.4.3.1.2. Food and Beverages
- 9.4.3.1.3. Personal Care & Cosmetics
- 9.4.3.1.4. Others
- 9.4.3.1. By Application
- 9.4.1. Brazil
10. Middle East & Africa Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Key Findings / Summary
- 10.2. By Source
- 10.2.1. Microbial
- 10.2.2. Plant-based
- 10.2.3. Animal-based
- 10.3. By Application
- 10.3.1. Pharmaceuticals
- 10.3.2. Food and Beverages
- 10.3.3. Personal Care & Cosmetics
- 10.3.4. Others
- 10.4. By Country
- 10.4.1. Saudi Arabia
- 10.4.1.1. By Application
- 10.4.1.1.1. Pharmaceuticals
- 10.4.1.1.2. Food and Beverages
- 10.4.1.1.3. Personal Care & Cosmetics
- 10.4.1.1.4. Others
- 10.4.1.1. By Application
- 10.4.2. South Africa
- 10.4.2.1. By Application
- 10.4.2.1.1. Pharmaceuticals
- 10.4.2.1.2. Food and Beverages
- 10.4.2.1.3. Personal Care & Cosmetics
- 10.4.2.1.4. Others
- 10.4.2.1. By Application
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Application
- 10.4.3.1.1. Pharmaceuticals
- 10.4.3.1.2. Food and Beverages
- 10.4.3.1.3. Personal Care & Cosmetics
- 10.4.3.1.4. Others
- 10.4.3.1. By Application
- 10.4.1. Saudi Arabia
11. Competitive Landscape
- 11.1. Company Market Share/Ranking Analysis, By Key Players, 2025
- 11.2. Company Profiles
- 11.2.1. Givaudan
- 11.2.1.1. Overview
- 11.2.1.2. Description
- 11.2.1.3. Product Portfolio
- 11.2.1.4. Financials (Data as available in the public domain and/or on paid databases)
- 11.2.1.5. Recent Developments
- 11.2.1. Givaudan
12. Similar information has been provided for all the below companies
- 12.1. Codex-ing Biotech Ingredients
- 12.1.1. Covalo
- 12.1.2. dsm-firmenich.
- 12.1.3. Abel
- 12.1.4. Aesthetics Rx
- 12.1.5. Nikko Chemicals Co., Ltd.
- 12.1.6. Evonik Personal Care
- 12.1.7. Fermenta Biotech Limited
- 12.1.8. Titan Biotech.
- 12.1.9. Conagen, Inc.
- 12.1.10. Advanced Biotech
- 12.1.11. Merck KGaA
13. Strategic Recommendations
List of Tables
- Table 1: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
- Table 2: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 3: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Region, 2021-2034
- Table 4: North America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
- Table 5: North America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 6: North America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
- Table 7: U.S. Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 8: Canada Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 9: Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
- Table 10: Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 11: Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
- Table 12: Germany Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 13: France Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 14: UK Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 15: Italy Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 16: Rest of Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 17: Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
- Table 18: Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 19: Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
- Table 20: China Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 21: India Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 22: Japan Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 23: South Korea Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 24: Rest of Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 25: Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
- Table 26: Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 27: Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
- Table 28: Brazil Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 29: Mexico Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 30: Rest of Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 31: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
- Table 32: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 33: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
- Table 34: Saudi Arabia Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 35: South Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
- Table 36: Rest of Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
List of Figures
- Figure 1: Global Biotech Ingredients Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
- Figure 2: Global Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
- Figure 3: Global Biotech Ingredients Market Revenue Share (%), By Source, 2025
- Figure 4: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Microbial, 2021-2034
- Figure 5: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Plant-based, 2021-2034
- Figure 6: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Animal-based, 2021-2034
- Figure 7: Global Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
- Figure 8: Global Biotech Ingredients Market Revenue Share (%), By Application, 2025
- Figure 9: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Pharmaceuticals, 2021-32
- Figure 10: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Food and Beverages, 2021-2034
- Figure 11: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Personal Care & Cosmetics, 2021-32
- Figure 12: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Others, 2021-32
- Figure 13: Global Biotech Ingredients Market Revenue (USD Billion), by Region, 2025 & 2034
- Figure 14: Global Biotech Ingredients Market Revenue Share (%), by Region, 2025
- Figure 15: North America Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
- Figure 16: North America Biotech Ingredients Market Revenue Share (%), By Source, 2025
- Figure 17: North America Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
- Figure 18: North America Biotech Ingredients Market Revenue Share (%), By Application, 2025
- Figure 19: North America Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
- Figure 20: North America Biotech Ingredients Market Revenue Share (%), by Country, 2025
- Figure 21: Europe Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
- Figure 22: Europe Biotech Ingredients Market Revenue Share (%), By Source, 2025
- Figure 23: Europe Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
- Figure 24: Europe Biotech Ingredients Market Revenue Share (%), By Application, 2025
- Figure 25: Europe Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
- Figure 26: Europe Biotech Ingredients Market Revenue Share (%), by Country, 2025
- Figure 27: Asia Pacific Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
- Figure 28: Asia Pacific Biotech Ingredients Market Revenue Share (%), By Source, 2025
- Figure 29: Asia Pacific Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
- Figure 30: Asia Pacific Biotech Ingredients Market Revenue Share (%), By Application, 2025
- Figure 31: Asia Pacific Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
- Figure 32: Asia Pacific Biotech Ingredients Market Revenue Share (%), by Country, 2025
- Figure 33: Latin America Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
- Figure 34: Latin America Biotech Ingredients Market Revenue Share (%), By Source, 2025
- Figure 35: Latin America Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
- Figure 36: Latin America Biotech Ingredients Market Revenue Share (%), By Application, 2025
- Figure 37: Latin America Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
- Figure 38: Latin America Biotech Ingredients Market Revenue Share (%), by Country, 2025
- Figure 39: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
- Figure 40: Middle East & Africa Biotech Ingredients Market Revenue Share (%), By Source, 2025
- Figure 41: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
- Figure 42: Middle East & Africa Biotech Ingredients Market Revenue Share (%), By Application, 2025
- Figure 43: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
- Figure 44: Middle East & Africa Biotech Ingredients Market Revenue Share (%), by Country, 2025
